Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 8 hrs 34 mins

S&P Futures
4,070.75
-14.00(-0.34%)
Dow Futures
32,505.00
-76.00(-0.23%)
Nasdaq Futures
12,488.75
-71.50(-0.57%)
Russell 2000 Futures
1,830.00
-7.20(-0.39%)
Crude Oil
113.03
+0.63(+0.56%)
Gold
1,807.10
-11.80(-0.65%)

Advertisement

Webinar

Yahoo Finance Plus presents 'Investing in the new high-inflation, slowing-growth paradigm'

Analyst Callie Cox joins Jared Blikre to help investors find opportunities in a tough market on Wed, May 18 at 2pm ET.

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

1.0700

+0.0300

(+2.88%)

At close: 04:00PM EDT

1.0456

-0.02

(-2.28%)

After hours:

05:53PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	1.0400
Open	1.0700
Bid	0.0000 x 2900
Ask	0.0000 x 1100
Day's Range	1.0300 - 1.1000
52 Week Range	0.9600 - 4.3100
Volume	2,184,779
Avg. Volume	2,071,926

Market Cap	275.316M
Beta (5Y Monthly)	1.96
PE Ratio (TTM)	N/A
EPS (TTM)	-0.2640
Earnings Date	Feb 28, 2022 - Mar 04, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	6.67

All

Simply Wall St.
Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Zacks
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 0% and 3.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., May 09, 2022--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the first quarter ending March 31, 2022 and provided a corporate update.

Advertisement

S&P Futures4,070.75-14.00(-0.34%)

Dow Futures32,505.00-76.00(-0.23%)

Nasdaq Futures12,488.75-71.50(-0.57%)

Russell 2000 Futures1,830.00-7.20(-0.39%)

Crude Oil113.03+0.63(+0.56%)

Gold1,807.10-11.80(-0.65%)

Yahoo Finance Plus presents 'Investing in the new high-inflation, slowing-growth paradigm'

VBI Vaccines Inc. (VBIV)

Chart Events

Performance Outlook

Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates

VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update

S&P Futures
4,070.75
-14.00(-0.34%)

Dow Futures
32,505.00
-76.00(-0.23%)

Nasdaq Futures
12,488.75
-71.50(-0.57%)

Russell 2000 Futures
1,830.00
-7.20(-0.39%)

Crude Oil
113.03
+0.63(+0.56%)

Gold
1,807.10
-11.80(-0.65%)